Sandra T. van Tiel

1.8k total citations
53 papers, 1.4k citations indexed

About

Sandra T. van Tiel is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sandra T. van Tiel has authored 53 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 13 papers in Immunology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sandra T. van Tiel's work include Immunotherapy and Immune Responses (10 papers), Angiogenesis and VEGF in Cancer (10 papers) and Sarcoma Diagnosis and Treatment (10 papers). Sandra T. van Tiel is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), Angiogenesis and VEGF in Cancer (10 papers) and Sarcoma Diagnosis and Treatment (10 papers). Sandra T. van Tiel collaborates with scholars based in Netherlands, Belgium and United States. Sandra T. van Tiel's co-authors include Timo L.M. ten Hagen, Ann L.B. Seynhaeve, A.M.M. Eggermont, Johannes H. W. de Wilt, Alexander M.M. Eggermont, E. A. de Bruijn, Alexander Eggermont, A.H. van der Veen, Monique R. Bernsen and Saske Hoving and has published in prestigious journals such as PLoS ONE, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Sandra T. van Tiel

53 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra T. van Tiel Netherlands 22 555 438 368 283 277 53 1.4k
Martina Rudelius Germany 24 595 1.1× 594 1.4× 264 0.7× 177 0.6× 225 0.8× 43 1.8k
Alessandro De Vita Italy 24 588 1.1× 654 1.5× 460 1.3× 243 0.9× 445 1.6× 74 1.7k
Edwardine Labay United States 12 540 1.0× 415 0.9× 167 0.5× 123 0.4× 224 0.8× 14 1.1k
Marta Vilalta United States 19 388 0.7× 389 0.9× 220 0.6× 110 0.4× 226 0.8× 25 1.1k
Manja Wobus Germany 23 864 1.6× 326 0.7× 484 1.3× 85 0.3× 139 0.5× 68 2.1k
Yan Ma United States 25 771 1.4× 353 0.8× 283 0.8× 106 0.4× 389 1.4× 67 1.6k
Taturo Udagawa United States 19 657 1.2× 388 0.9× 160 0.4× 103 0.4× 152 0.5× 27 1.3k
Eric A. Murphy United States 11 1.2k 2.2× 344 0.8× 267 0.7× 330 1.2× 173 0.6× 20 1.9k
Emmanuelle DiTomaso United States 5 631 1.1× 340 0.8× 391 1.1× 134 0.5× 239 0.9× 15 1.4k
Jay George United States 11 502 0.9× 560 1.3× 470 1.3× 170 0.6× 80 0.3× 11 1.5k

Countries citing papers authored by Sandra T. van Tiel

Since Specialization
Citations

This map shows the geographic impact of Sandra T. van Tiel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra T. van Tiel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra T. van Tiel more than expected).

Fields of papers citing papers by Sandra T. van Tiel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra T. van Tiel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra T. van Tiel. The network helps show where Sandra T. van Tiel may publish in the future.

Co-authorship network of co-authors of Sandra T. van Tiel

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra T. van Tiel. A scholar is included among the top collaborators of Sandra T. van Tiel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra T. van Tiel. Sandra T. van Tiel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Utomo, Lizette, Niamh Fahy, Nicole Kops, et al.. (2019). Peripheral blood monocyte and synovial macrophage subsets in the mouse model of osteoarthritis induced by destabilization of the medial meniscus. Osteoarthritis and Cartilage. 27. S376–S376. 1 indexed citations
2.
Tiel, Sandra T. van, Joost Haeck, Gabriela N. Doeswijk, et al.. (2018). In Vivo Stabilized SB3, an Attractive GRPR Antagonist, for Pre- and Intra-Operative Imaging for Prostate Cancer. Molecular Imaging and Biology. 20(6). 973–983. 14 indexed citations
3.
Skachkov, Ilya, Ying Luan, Sandra T. van Tiel, et al.. (2018). SPIO labeling of endothelial cells using ultrasound and targeted microbubbles at diagnostic pressures. PLoS ONE. 13(9). e0204354–e0204354. 3 indexed citations
4.
Tiel, Sandra T. van, et al.. (2016). Imaging inflammation in the knee joint with 111IN-octreoscan. Osteoarthritis and Cartilage. 24. S320–S320. 2 indexed citations
5.
Duinhouwer, Lucia, Sandra T. van Tiel, Gabriela N. Doeswijk, et al.. (2015). Magnetic Resonance Detection of CD34+ Cells from Umbilical Cord Blood Using a 19F Label. PLoS ONE. 10(9). e0138572–e0138572. 7 indexed citations
6.
Flohil, S.C., Charlotte M. Proby, Sandra T. van Tiel, et al.. (2012). Basal cell carcinomas without histological confirmation and their treatment: an audit in four European regions. British Journal of Dermatology. 167. 22–28. 17 indexed citations
7.
Farrell, Eric, Piotr A. Wielopolski, Sandra T. van Tiel, et al.. (2008). Effects of iron oxide incorporation for long term cell tracking on MSC differentiation in vitro and in vivo. Biochemical and Biophysical Research Communications. 369(4). 1076–1081. 119 indexed citations
8.
Seynhaeve, Ann L.B., Saske Hoving, Debby Schipper, et al.. (2007). Tumor Necrosis Factor α Mediates Homogeneous Distribution of Liposomes in Murine Melanoma that Contributes to a Better Tumor Response. Cancer Research. 67(19). 9455–9462. 142 indexed citations
9.
Brunstein, Flávia, Joost A.P. Rens, Sandra T. van Tiel, Alexander M.M. Eggermont, & Timo L.M. ten Hagen. (2006). Histamine, a vasoactive agent with vascular disrupting potential, improves tumour response by enhancing local drug delivery. British Journal of Cancer. 95(12). 1663–1669. 14 indexed citations
10.
Hagen, Timo L.M. ten, et al.. (2004). Lack of efficacy of Doxil® in TNF-α-based isolated limb perfusion in sarcoma-bearing rats. British Journal of Cancer. 90(9). 1830–1832. 3 indexed citations
11.
Etten, Boudewijn van, Mark R. de Vries, Marc G. A. van Ijken, et al.. (2003). Degree of tumour vascularity correlates with drug accumulation and tumour response upon TNF-α-based isolated hepatic perfusion. British Journal of Cancer. 88(2). 314–319. 39 indexed citations
12.
Seynhaeve, Ann L.B., Johannes H. W. de Wilt, Sandra T. van Tiel, A.M.M. Eggermont, & Timo L.M. ten Hagen. (2002). Isolated limb perfusion with actinomycin D and TNF-alpha results in improved tumour response in soft-tissue sarcoma-bearing rats but is accompanied by severe local toxicity. British Journal of Cancer. 86(7). 1174–1179. 23 indexed citations
13.
Lans, Titia E., Timo L.M. ten Hagen, Remco van Horssen, et al.. (2002). Improved antitumor response to isolated limb perfusion with tumor necrosis factor after upregulation of endothelial monocyte-activating polypeptide II in soft tissue sarcoma. Annals of Surgical Oncology. 9(8). 812–819. 16 indexed citations
14.
Seynhaeve, Ann L.B., Johannes H. W. de Wilt, Sandra T. van Tiel, A. M. M. Eggermont, & Timo L.M. ten Hagen. (2002). Isolated limb perfusion with actinomycin D and TNF-alpha results in improved tumour response in soft-tissue sarcoma-bearing rats but is accompanied by severe local toxicity. British Journal of Cancer. 86(7). 1174–1179. 2 indexed citations
15.
Hagen, Timo L.M. ten, Ann L.B. Seynhaeve, Sandra T. van Tiel, Dirk J. Ruiter, & Alexander M.M. Eggermont. (2001). Pegylated liposomal tumor necrosis factor‐α results in reduced toxicity and synergistic antitumor activity after systemic administration in combination with liposomal doxorubicin (Doxil®) in soft tissue sarcoma‐bearing rats. International Journal of Cancer. 97(1). 115–120. 53 indexed citations
16.
Wilt, Johannes H. W. de, Eric R. Manusama, Boudewijn van Etten, et al.. (2000). Nitric oxide synthase inhibition results in synergistic anti-tumour activity with melphalan and tumour necrosis factor alpha-based isolated limb perfusions. British Journal of Cancer. 83(9). 1176–1182. 40 indexed citations
17.
Wilt, Johannes H. W. de, Timo L.M. ten Hagen, Gert De Boeck, et al.. (2000). Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion. British Journal of Cancer. 82(5). 1000–1003. 158 indexed citations
18.
Wilt, Johannes H. W. de, Eric R. Manusama, Sandra T. van Tiel, et al.. (1999). Prerequisites for effective isolated limb perfusion using tumour necrosis factor alpha and melphalan in rats. British Journal of Cancer. 80(1-2). 161–166. 2 indexed citations
19.
Veen, A.H. van der, Alexander M.M. Eggermont, Ann L.B. Seynhaeve, Sandra T. van Tiel, & Timo L.M. ten Hagen. (1998). Biodistribution and tumor localization of stealth liposomal tumor necrosis factor-α in soft tissue sarcoma bearing rats. International Journal of Cancer. 77(6). 901–906. 42 indexed citations
20.
Veen, A.H. van der, Alexander Eggermont, Ann L.B. Seynhaeve, Sandra T. van Tiel, & Timo L.M. ten Hagen. (1998). Biodistribution and tumor localization of stealth liposomal tumor necrosis factor‐α in soft tissue sarcoma bearing rats. International Journal of Cancer. 77(6). 901–906. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026